Effect of oxprenolol on adrenaline-evoked ventricular arrhythmias in dogs anaesthetized with halothane in oxygen.
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000605:Amino Alcohols / Q000627:therapeutic use*; D000769:Anesthesia, Inhalation; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D001285:Atropine; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D004554:Electric Countershock; D004837:Epinephrine; D005260:Female; D006221:Halothane; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D010100:Oxygen; D011433:Propranolol / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use*
D000318:Adrenergic beta-Agonists; D000605:Amino Alcohols; D013565:Sympatholytics; D001285:Atropine; D011433:Propranolol; D010100:Oxygen; D006221:Halothane; D004837:Epinephrine